Earnings Call · Q2 FY2022·2022-08-11

Q2 22EPS +22.22%·Rev n/aQ1 22EPS +10.00%·Rev n/aQ4 21EPS -25.00%·Rev n/aQ3 21EPS +11.11%·Rev n/a⚠ consensus missing

GERON CORP GERN

Aron Feingold — Vice President of Investor Relations and Corporate Communications

Dr. John Scarlett — Chairman and Chief Executive Officer

Dr. Faye Feller — Senior Executive / Clinical Development

Olivia Bloom — Senior Financial Officer

+14.6%1d on move date+12.9% vs SPY3d+8.3%5d+6.8%

Research tier

Behavioral profile computed for 4 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more GERN calls or request research access.

More GERN calls Browse calls Request research access